vs

Side-by-side financial comparison of PROVIDENT FINANCIAL HOLDINGS INC (PROV) and AVITA Medical, Inc. (RCEL). Click either name above to swap in a different company.

AVITA Medical, Inc. is the larger business by last-quarter revenue ($17.6M vs $9.8M, roughly 1.8× PROVIDENT FINANCIAL HOLDINGS INC). PROVIDENT FINANCIAL HOLDINGS INC runs the higher net margin — 14.6% vs -66.0%, a 80.6% gap on every dollar of revenue. On growth, PROVIDENT FINANCIAL HOLDINGS INC posted the faster year-over-year revenue change (2.5% vs -4.3%). PROVIDENT FINANCIAL HOLDINGS INC produced more free cash flow last quarter ($1.0M vs $-6.1M). Over the past eight quarters, AVITA Medical, Inc.'s revenue compounded faster (26.0% CAGR vs 2.3%).

Provident Financial Holdings Inc is a bank holding company operating through its subsidiary Provident Savings Bank. It offers retail and commercial banking services including deposit products, mortgage loans, consumer lending and small business financing for local communities across California.

Avita Medical is a clinical and commercial company developing and marketing a range regenerative medicine products. The first regenerative medicine product brought to the market by Avita Medical was ReCell spray-on skin for the treatment of burns. The two latest products are ReNovaCell, for Aesthetics and Plastic applications including skin trauma, and ReGenerCell for the treatment of chronic wounds. The Avita Medical regenerative product range is currently marketed in Europe, the Middle East...

PROV vs RCEL — Head-to-Head

Bigger by revenue
RCEL
RCEL
1.8× larger
RCEL
$17.6M
$9.8M
PROV
Growing faster (revenue YoY)
PROV
PROV
+6.8% gap
PROV
2.5%
-4.3%
RCEL
Higher net margin
PROV
PROV
80.6% more per $
PROV
14.6%
-66.0%
RCEL
More free cash flow
PROV
PROV
$7.1M more FCF
PROV
$1.0M
$-6.1M
RCEL
Faster 2-yr revenue CAGR
RCEL
RCEL
Annualised
RCEL
26.0%
2.3%
PROV

Income Statement — Q2 FY2026 vs Q4 FY2025

Metric
PROV
PROV
RCEL
RCEL
Revenue
$9.8M
$17.6M
Net Profit
$1.4M
$-11.6M
Gross Margin
81.2%
Operating Margin
20.8%
-59.1%
Net Margin
14.6%
-66.0%
Revenue YoY
2.5%
-4.3%
Net Profit YoY
64.7%
-0.3%
EPS (diluted)
$0.22
$-0.37

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PROV
PROV
RCEL
RCEL
Q4 25
$9.8M
$17.6M
Q3 25
$9.7M
$17.1M
Q2 25
$9.8M
$18.4M
Q1 25
$10.1M
$18.5M
Q4 24
$9.6M
$18.4M
Q3 24
$9.5M
$19.5M
Q2 24
$9.9M
$15.2M
Q1 24
$9.4M
$11.1M
Net Profit
PROV
PROV
RCEL
RCEL
Q4 25
$1.4M
$-11.6M
Q3 25
$1.7M
$-13.2M
Q2 25
$1.6M
$-9.9M
Q1 25
$1.9M
$-13.9M
Q4 24
$872.0K
$-11.6M
Q3 24
$1.9M
$-16.2M
Q2 24
$2.0M
$-15.4M
Q1 24
$1.5M
$-18.7M
Gross Margin
PROV
PROV
RCEL
RCEL
Q4 25
81.2%
Q3 25
81.3%
Q2 25
81.2%
Q1 25
84.7%
Q4 24
87.6%
Q3 24
83.7%
Q2 24
86.1%
Q1 24
86.4%
Operating Margin
PROV
PROV
RCEL
RCEL
Q4 25
20.8%
-59.1%
Q3 25
28.1%
-53.6%
Q2 25
23.6%
-60.5%
Q1 25
26.2%
-63.9%
Q4 24
12.7%
-54.1%
Q3 24
28.3%
-70.6%
Q2 24
27.8%
-102.8%
Q1 24
22.5%
-155.0%
Net Margin
PROV
PROV
RCEL
RCEL
Q4 25
14.6%
-66.0%
Q3 25
17.3%
-77.3%
Q2 25
16.7%
-53.9%
Q1 25
18.4%
-74.9%
Q4 24
9.1%
-63.0%
Q3 24
20.0%
-82.9%
Q2 24
19.7%
-101.3%
Q1 24
15.9%
-168.0%
EPS (diluted)
PROV
PROV
RCEL
RCEL
Q4 25
$0.22
$-0.37
Q3 25
$0.25
$-0.46
Q2 25
$0.24
$-0.38
Q1 25
$0.28
$-0.53
Q4 24
$0.13
$-0.44
Q3 24
$0.28
$-0.62
Q2 24
$0.28
$-0.60
Q1 24
$0.22
$-0.73

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PROV
PROV
RCEL
RCEL
Cash + ST InvestmentsLiquidity on hand
$54.4M
$18.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$127.5M
$-16.6M
Total Assets
$1.2B
$56.4M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PROV
PROV
RCEL
RCEL
Q4 25
$54.4M
$18.2M
Q3 25
$49.4M
$23.3M
Q2 25
$53.1M
$15.7M
Q1 25
$50.9M
$25.8M
Q4 24
$45.5M
$35.9M
Q3 24
$48.2M
$44.4M
Q2 24
$51.4M
$54.1M
Q1 24
$51.7M
$68.2M
Stockholders' Equity
PROV
PROV
RCEL
RCEL
Q4 25
$127.5M
$-16.6M
Q3 25
$128.4M
$-6.7M
Q2 25
$128.5M
$-12.9M
Q1 25
$128.9M
$-4.6M
Q4 24
$128.6M
$4.5M
Q3 24
$129.6M
$12.2M
Q2 24
$129.9M
$23.9M
Q1 24
$129.5M
$32.6M
Total Assets
PROV
PROV
RCEL
RCEL
Q4 25
$1.2B
$56.4M
Q3 25
$1.2B
$63.7M
Q2 25
$1.2B
$58.1M
Q1 25
$1.3B
$69.6M
Q4 24
$1.3B
$79.7M
Q3 24
$1.3B
$81.1M
Q2 24
$1.3B
$87.8M
Q1 24
$1.3B
$97.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PROV
PROV
RCEL
RCEL
Operating Cash FlowLast quarter
$1.2M
$-5.4M
Free Cash FlowOCF − Capex
$1.0M
$-6.1M
FCF MarginFCF / Revenue
10.5%
-34.7%
Capex IntensityCapex / Revenue
1.9%
3.8%
Cash ConversionOCF / Net Profit
0.85×
TTM Free Cash FlowTrailing 4 quarters
$14.9M
$-33.5M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PROV
PROV
RCEL
RCEL
Q4 25
$1.2M
$-5.4M
Q3 25
$2.5M
$-5.2M
Q2 25
$8.7M
$-10.2M
Q1 25
$3.3M
$-10.3M
Q4 24
$324.0K
$-8.1M
Q3 24
$2.6M
$-7.2M
Q2 24
$5.7M
$-12.8M
Q1 24
$3.0M
$-20.9M
Free Cash Flow
PROV
PROV
RCEL
RCEL
Q4 25
$1.0M
$-6.1M
Q3 25
$2.5M
$-6.2M
Q2 25
$8.2M
$-10.8M
Q1 25
$3.3M
$-10.5M
Q4 24
$307.0K
$-9.7M
Q3 24
$2.4M
$-11.0M
Q2 24
$4.1M
$-15.4M
Q1 24
$2.6M
$-22.0M
FCF Margin
PROV
PROV
RCEL
RCEL
Q4 25
10.5%
-34.7%
Q3 25
25.2%
-36.1%
Q2 25
83.5%
-58.4%
Q1 25
32.5%
-56.9%
Q4 24
3.2%
-52.7%
Q3 24
25.1%
-56.1%
Q2 24
41.3%
-101.6%
Q1 24
27.5%
-198.2%
Capex Intensity
PROV
PROV
RCEL
RCEL
Q4 25
1.9%
3.8%
Q3 25
0.5%
5.5%
Q2 25
5.4%
2.8%
Q1 25
0.3%
1.2%
Q4 24
0.2%
8.8%
Q3 24
1.8%
19.2%
Q2 24
16.0%
17.5%
Q1 24
4.2%
10.3%
Cash Conversion
PROV
PROV
RCEL
RCEL
Q4 25
0.85×
Q3 25
1.48×
Q2 25
5.34×
Q1 25
1.79×
Q4 24
0.37×
Q3 24
1.35×
Q2 24
2.91×
Q1 24
2.00×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons